| USD ($) $ in Millions | LTM | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities | ||||||||||||||||||
Cash flows from operating activities | ||||||||||||||||||
Net earnings | $ 20,973 | $ 17,176 | $ 14,276 | $ 8,516 | ||||||||||||||
Adjustments to reconcile net earnings to net cash used for operating activities: | ||||||||||||||||||
Depreciation and amortization | 2,062 | 2,182 | 2,392 | 4,856 | ||||||||||||||
Deferred income taxes | (82) | 204 | (800) | (1,360) | ||||||||||||||
Share-based compensation | 3,464 | 3,445 | 2,663 | 2,085 | ||||||||||||||
Gain on sale of European insurance business | - | - | - | - | ||||||||||||||
Gain related to extinguishment of unsecured borrowings | - | - | - | - | ||||||||||||||
Provision for credit losses | (1,367) | (1,113) | 1,348 | 1,028 | ||||||||||||||
Changes in operating assets and liabilities: | ||||||||||||||||||
Customer and other receivables and payables, net | (7,587) | (43,206) | (8,367) | (28,219) | ||||||||||||||
Cash and securities segregated for regulatory and other purposes | - | - | - | - | ||||||||||||||
Receivables and payables (excluding loans receivable), net | - | - | - | - | ||||||||||||||
Collateralized transactions (excluding other secured financings), net | 34,879 | (12,891) | 68,582 | 160,227 | ||||||||||||||
Net receivables from brokers, dealers and clearing organizations | - | - | - | - | ||||||||||||||
Net payables to customers and counterparties | - | - | - | - | ||||||||||||||
Securities borrowed, net of securities loaned | - | - | - | - | ||||||||||||||
Securities sold under agreements to repurchase, net of securities purchased under agreements to resell and federal funds sold | - | - | - | - | ||||||||||||||
Trading assets | (154,818) | (69,866) | (86,991) | (163,807) | ||||||||||||||
Trading assets | - | - | - | - | ||||||||||||||
Trading assets, at fair value | - | - | - | - | ||||||||||||||
Trading liabilities | 64,126 | 57,560 | (212) | 5,751 | ||||||||||||||
Loans held for sale, net | (1,587) | (504) | 537 | 1,635 | ||||||||||||||
Financial instruments sold, but not yet purchased | - | - | - | - | ||||||||||||||
Financial instruments sold, but not yet purchased, at fair value | - | - | - | - | ||||||||||||||
Other, net | 578 | 1,859 | (6,640) | (3,299) | ||||||||||||||
Net cash used for operating activities | (39,359) | (45,154) | (13,212) | (12,587) | ||||||||||||||
Cash flows from investing activities | ||||||||||||||||||
Cash flows from investing activities | ||||||||||||||||||
Purchase of property, leasehold improvements and equipment | (2,156) | (2,064) | (2,091) | (2,316) | ||||||||||||||
Proceeds from sales of property, leasehold improvements and equipment | 620 | 803 | 1,613 | 3,278 | ||||||||||||||
Net cash received from business dispositions | (247) | 1,536 | 3,622 | - | ||||||||||||||
Available-for-sale securities: | ||||||||||||||||||
Purchases | (108,503) | (77,429) | (60,852) | - | ||||||||||||||
Proceeds from sales | 55,224 | 61,325 | 19,005 | - | ||||||||||||||
Proceeds from paydowns and maturities | 251 | 43 | 12,809 | - | ||||||||||||||
Held-to-maturity securities: | ||||||||||||||||||
Purchases | (19,096) | (11,279) | (23,018) | - | ||||||||||||||
Proceeds from paydowns and maturities | 17,883 | 21,687 | 15,549 | - | ||||||||||||||
Other investments: | ||||||||||||||||||
Purchases | (10,162) | (9,392) | (8,226) | - | ||||||||||||||
Proceeds from sales, paydowns and maturities | 11,652 | 9,892 | 9,010 | - | ||||||||||||||
Net cash received from/(used for) business dispositions or acquisitions | - | - | - | 487 | ||||||||||||||
Purchase of investments | - | - | - | (40,256) | ||||||||||||||
Proceeds from sales and paydowns of investments | - | - | - | 26,848 | ||||||||||||||
Proceeds from sales of investments | - | - | - | - | ||||||||||||||
Loans (excluding loans held for sale), net | (40,491) | (39,349) | (17,045) | (5,353) | ||||||||||||||
Purchase of available-for-sale securities | - | - | - | - | ||||||||||||||
Proceeds from sales of available-for-sale securities | - | - | - | - | ||||||||||||||
Loans held for investment, net | - | - | - | - | ||||||||||||||
Net cash used for investing activities | (95,025) | (44,227) | (49,624) | (17,312) | ||||||||||||||
Cash flows from financing activities | ||||||||||||||||||
Cash flows from financing activities | ||||||||||||||||||
Unsecured short-term borrowings, net | 11,138 | 2,988 | 934 | 2,050 | ||||||||||||||
Other secured financings (short-term), net | 14,001 | (3,877) | 13,707 | 673 | ||||||||||||||
Proceeds from issuance of other secured financings (long-term) | 10,431 | 6,510 | 5,243 | 3,047 | ||||||||||||||
Repayment of other secured financings (long-term), including the current portion | (5,360) | (3,331) | (2,036) | (3,570) | ||||||||||||||
Repayment of unsecured long-term borrowings, including the current portion | (76,114) | (71,502) | (74,519) | (54,066) | ||||||||||||||
Purchase of Trust Preferred securities | - | - | - | - | ||||||||||||||
Proceeds from issuance of unsecured long-term borrowings | 145,618 | 88,196 | 67,252 | 47,153 | ||||||||||||||
Purchase of APEX, senior guaranteed securities and trust preferred securities | - | - | - | - | ||||||||||||||
Derivative contracts with a financing element, net | 4,163 | 2,313 | 2,390 | 3,280 | ||||||||||||||
Repurchase of common stock warrants | - | - | - | - | ||||||||||||||
Deposits, net | 93,119 | 62,783 | 5,894 | 39,723 | ||||||||||||||
Preferred stock redemption | (2,125) | 0 | (2,200) | (1,000) | ||||||||||||||
Common stock repurchased | (14,000) | (12,360) | (8,000) | (5,796) | ||||||||||||||
Settlement of share-based awards in satisfaction of withholding tax requirements | (2,874) | (2,156) | (1,331) | (1,345) | ||||||||||||||
Dividends and dividend equivalents paid on common stock, preferred stock and share-based awards | (6,130) | (5,277) | (4,497) | (4,189) | ||||||||||||||
Proceeds from issuance of preferred stock, net of issuance costs | 0 | 1,895 | 4,239 | 1,496 | ||||||||||||||
Other financing, net | (121) | (82) | 247 | 344 | ||||||||||||||
Proceeds from issuance of common stock, including exercise of share-based awards | - | - | - | - | ||||||||||||||
Net cash provided by financing activities | 171,746 | 66,100 | 7,323 | 27,800 | ||||||||||||||
Cash settlement of share-based awards | - | - | - | - | ||||||||||||||
Proceeds from issuance of common stock warrants | - | - | - | - | ||||||||||||||
Excess tax benefit related to share-based awards | - | - | - | - | ||||||||||||||
Cash settlement of share-based compensation | - | - | - | - | ||||||||||||||
Net cash provided by financing activities | - | - | - | - | ||||||||||||||
Net decrease in cash and cash equivalents | 34,299 | (17,833) | (59,485) | (248) | ||||||||||||||
Effect of exchange rate changes on cash and cash equivalents | (3,063) | 5,448 | (3,972) | 1,851 | ||||||||||||||
Net increase in cash and cash equivalents | - | - | - | - | ||||||||||||||
Supplemental disclosures: | ||||||||||||||||||
Cash payments for interest, net of capitalized interest | 67,014 | 65,494 | 72,623 | 60,026 | ||||||||||||||
Cash payments for income taxes, net | - | 3,990 | 3,673 | 2,389 | ||||||||||||||
Non-cash activities: | ||||||||||||||||||
Approximate increase in assets upon adoption of ASU No. 2009-17 | - | - | - | - | ||||||||||||||
Approximate increase in liabilities upon adoption of ASU No. 2009-17 | - | - | - | - | ||||||||||||||
Common stock issued in connection with business acquisitions | - | - | - | - | ||||||||||||||
Debt assumed in connection with business acquisitions | - | - | - | - |